An Overview of the Parameters for Recombinant Protein Expression in Escherichia coli

B. C. Joseph, Suthakaran Pichaimuthu, S. Srimeenakshi, M. Murthy, K. Selvakumar, M. Ganesan, Sadan, A. Manjunath
{"title":"An Overview of the Parameters for Recombinant Protein Expression in Escherichia coli","authors":"B. C. Joseph, Suthakaran Pichaimuthu, S. Srimeenakshi, M. Murthy, K. Selvakumar, M. Ganesan, Sadan, A. Manjunath","doi":"10.4172/2157-7013.1000221","DOIUrl":null,"url":null,"abstract":"Escherichia coli, is one of the most widely preferred organism for the production of recombinant protein. Most of the FDA approved therapeutic proteins are produced in E. coli. The well-established cell factory of E. coli makes it a perfect heterologous system of choice for the production of recombinant proteins. In recent years, several advances have been taken place for modifying these cell factories for easy production of therapeutic proteins with utmost precision. Several molecular tools and protocols are available in hand for the high level protein production in heterologous expression system. Adapting the best strategy for producing recombinant proteins in E. coli can be obtained using several approaches. Combination of strategies will work well to enhance the expression and stability of produced protein. In this review we try to collate different strategies and approaches that can enhance the production as well as the stability of proteins expressed in E. coli.","PeriodicalId":150547,"journal":{"name":"Journal of Cell Science and Therapy","volume":"50 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"60","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cell Science and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2157-7013.1000221","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 60

Abstract

Escherichia coli, is one of the most widely preferred organism for the production of recombinant protein. Most of the FDA approved therapeutic proteins are produced in E. coli. The well-established cell factory of E. coli makes it a perfect heterologous system of choice for the production of recombinant proteins. In recent years, several advances have been taken place for modifying these cell factories for easy production of therapeutic proteins with utmost precision. Several molecular tools and protocols are available in hand for the high level protein production in heterologous expression system. Adapting the best strategy for producing recombinant proteins in E. coli can be obtained using several approaches. Combination of strategies will work well to enhance the expression and stability of produced protein. In this review we try to collate different strategies and approaches that can enhance the production as well as the stability of proteins expressed in E. coli.
重组蛋白在大肠杆菌中的表达参数综述
大肠杆菌是生产重组蛋白的最广泛首选的生物之一。大多数FDA批准的治疗性蛋白质都是在大肠杆菌中产生的。大肠杆菌完善的细胞工厂使其成为生产重组蛋白的完美异种系统的选择。近年来,已经取得了一些进展,修改这些细胞工厂,使其易于生产治疗性蛋白质,并具有极高的精度。目前已有几种分子工具和方案可用于在异源表达系统中进行高水平的蛋白生产。在大肠杆菌中适应生产重组蛋白的最佳策略可以通过几种方法获得。这些策略的结合将很好地提高所产蛋白的表达和稳定性。在这篇综述中,我们试图整理不同的策略和方法,可以提高生产和蛋白质表达在大肠杆菌的稳定性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信